GPT and Hyperkalemia: There was no difference in alkaline phosphatase (AKP) increase, aspartate transaminase (AST) and/or alanine transaminase (ALT) increase, anemia, leukopenia, platelet decrease, eosinophilia, hyperkalemia and microalbuminuria between telavancin group and control group (Figure 6).